Cargando…
Social determinants of stage IV anal cancer and the impact of pelvic radiotherapy in the metastatic setting
Anal cancer is a relatively rare malignancy, and a minority of patients present with metastatic disease in the United States. The National Cancer Database (NCDB) was used to identify factors associated with metastatic disease at presentation and evaluate the role of pelvic radiotherapy in these pati...
Autores principales: | Repka, Michael C., Aghdam, Nima, Karlin, Andrew W., Unger, Keith R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673908/ https://www.ncbi.nlm.nih.gov/pubmed/28980407 http://dx.doi.org/10.1002/cam4.1203 |
Ejemplares similares
-
Ethnicity and insurance status predict metastatic disease presentation in prostate, breast, and non‐small cell lung cancer
por: Aghdam, Nima, et al.
Publicado: (2020) -
Modeling early haematologic adverse events in conformal and intensity-modulated pelvic radiotherapy in anal cancer
por: Robinson, Maxwell, et al.
Publicado: (2015) -
Clinical outcomes of definitive whole pelvic radiotherapy for clinical lymph node metastatic prostate cancer
por: Tsuchida, Keisuke, et al.
Publicado: (2020) -
Metastatic patterns and survival outcomes in patients with stage IV colon cancer: A population‐based analysis
por: Wang, Jiwei, et al.
Publicado: (2019) -
Radiotherapy improves the survival of patients with stage IV NSCLC: A propensity score matched analysis of the SEER database
por: Zhang, Rui, et al.
Publicado: (2018)